ReP USP - Resultado da busca

Filtros : "Center of Comparative Medicine and Pathology. Memorial Sloan-Kettering Cancer Center. Weill Cornell Medicine and the Hospital for Special Surgery. New York City, New York" Limpar

Filtros

Language
- inglês (~2)
Source title
- advances in biological regulation (~2)
Publisher
Conference titles
Countries/Territories
- holanda (~2)
Grupo de pesquisa
Funding Agencies
- financiamento ecu (~2)
- financiamento ncn (~2)
- financiamento intesa san paolo fondazione (~1)
Indexado em
Collaboration
Normalized affiliation
Non normalized affiliation
- center of comparative medicine and pathology. memorial sloan-kettering cancer center. weill cornell medicine and the hospital for special surgery. new york city, new york (2)
- department of biomedical and biotechnological sciences. oncological, clinical and general pathology section. university of catania. catania (2)
- department of microbiology and immunology. brody school of medicine at east carolina university. greenville, nc (2)
- department of molecular physiology and neurobiology. wroclaw university. wroclaw (2)
- department of physiological sciences. piracicaba dental school. state university of campinas. piracicaba, sp (2)

Countries of institutions of collaboration
- brasil (2)
- estados unidos (2)
- itália (2)
- polônia (2)
- austrália (1)

Artigo de periodico
Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells (2020)
Akula, Shaw M; Candido, Saverio; Abrams, Stephen L; Steelman, Linda S; Lertpiriyapong, Kvin; Cocco, Lucio; Ramazzotti, Giulia; Ratti, Stefano; Follo, Matilde Y; Martelli, Alberto M; Murata, Ramiro M; Rosalen, Pedro L; Bueno-Silva, Bruno; Alencar, Severino Matias de ; Falasca, Marco; Montalto, Giuseppe; Cervello, Melchiorre; Notarbartolo, Monica; Gizak, Agnieszka; Rakus, Dariusz; Libra, Massimo; McCubrey, James A
Source: Advances in Biological Regulation. Unidade: ESALQ
Subjects: ESTRADIOL, NEOPLASIAS PANCREÁTICAS, PRODUTOS NATURAIS, QUIMIOTERÁPICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AKULA, Shaw M et al. Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells. Advances in Biological Regulation, v. 75, p. 1-15, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.jbior.2019.100672. Acesso em: 17 jul. 2024.
APA
Akula, S. M., Candido, S., Abrams, S. L., Steelman, L. S., Lertpiriyapong, K., Cocco, L., et al. (2020). Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells. Advances in Biological Regulation, 75, 1-15. doi:10.1016/j.jbior.2019.100672
NLM
Akula SM, Candido S, Abrams SL, Steelman LS, Lertpiriyapong K, Cocco L, Ramazzotti G, Ratti S, Follo MY, Martelli AM, Murata RM, Rosalen PL, Bueno-Silva B, Alencar SM de, Falasca M, Montalto G, Cervello M, Notarbartolo M, Gizak A, Rakus D, Libra M, McCubrey JA. Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells [Internet]. Advances in Biological Regulation. 2020 ; 75 1-15.[citado 2024 jul. 17 ] Available from: https://doi.org/10.1016/j.jbior.2019.100672
Vancouver
Akula SM, Candido S, Abrams SL, Steelman LS, Lertpiriyapong K, Cocco L, Ramazzotti G, Ratti S, Follo MY, Martelli AM, Murata RM, Rosalen PL, Bueno-Silva B, Alencar SM de, Falasca M, Montalto G, Cervello M, Notarbartolo M, Gizak A, Rakus D, Libra M, McCubrey JA. Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells [Internet]. Advances in Biological Regulation. 2020 ; 75 1-15.[citado 2024 jul. 17 ] Available from: https://doi.org/10.1016/j.jbior.2019.100672
Artigo de periodico
Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells (2019)
Akula, Shaw M; Candido, Saverio; Libra, Massimo; Abrams, Stephen L; Steelman, Linda S; Lertpiriyapong, Kvin; Ramazzotti, Giulia; Ratti, Stefano; Follo, Matilde Y; Martelli, Alberto M; Murata, Ramiro M; Rosalen, Pedro L; Bueno-Silva, Bruno; Alencar, Severino Matias de; Montalto, Giuseppe; Cervello, Melchiorre; Gizak, Agnieszka; Rakus, Dariusz; Mao, Weifeng; Lin, Heng-Liang; Lombardi, Paolo; McCubrey, James A
Source: Advances in Biological Regulation. Unidade: ESALQ
Subjects: NEOPLASIAS PANCREÁTICAS, INIBIDORES DE ENZIMAS, TRANSDUÇÃO DE SINAL CELULAR, METFORMINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AKULA, Shaw M et al. Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells. Advances in Biological Regulation, p. 1-19, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.jbior.2019.04.003. Acesso em: 17 jul. 2024.
APA
Akula, S. M., Candido, S., Libra, M., Abrams, S. L., Steelman, L. S., Lertpiriyapong, K., et al. (2019). Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells. Advances in Biological Regulation, 1-19. doi:10.1016/j.jbior.2019.04.003
NLM
Akula SM, Candido S, Libra M, Abrams SL, Steelman LS, Lertpiriyapong K, Ramazzotti G, Ratti S, Follo MY, Martelli AM, Murata RM, Rosalen PL, Bueno-Silva B, Alencar SM de, Montalto G, Cervello M, Gizak A, Rakus D, Mao W, Lin H-L, Lombardi P, McCubrey JA. Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells [Internet]. Advances in Biological Regulation. 2019 ; 1-19.[citado 2024 jul. 17 ] Available from: https://doi.org/10.1016/j.jbior.2019.04.003
Vancouver
Akula SM, Candido S, Libra M, Abrams SL, Steelman LS, Lertpiriyapong K, Ramazzotti G, Ratti S, Follo MY, Martelli AM, Murata RM, Rosalen PL, Bueno-Silva B, Alencar SM de, Montalto G, Cervello M, Gizak A, Rakus D, Mao W, Lin H-L, Lombardi P, McCubrey JA. Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells [Internet]. Advances in Biological Regulation. 2019 ; 1-19.[citado 2024 jul. 17 ] Available from: https://doi.org/10.1016/j.jbior.2019.04.003

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2024